| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99199 |
Unlisted special service, procedure or report |
217,745 |
108,628 |
$1.81M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,214 |
4,991 |
$534K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,940 |
6,130 |
$469K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,518 |
2,945 |
$315K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,756 |
2,279 |
$268K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,654 |
2,211 |
$241K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,701 |
1,388 |
$147K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,983 |
3,325 |
$127K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,654 |
5,531 |
$126K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,316 |
1,053 |
$47K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,108 |
4,164 |
$45K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
836 |
668 |
$40K |
| 96127 |
|
7,810 |
6,102 |
$40K |
| 99383 |
|
294 |
281 |
$30K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
248 |
242 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
797 |
659 |
$21K |
| 99384 |
|
192 |
166 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,538 |
1,264 |
$20K |
| D0145 |
Oral evaluation for a patient under three years of age |
688 |
615 |
$19K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
375 |
318 |
$14K |
| 0001A |
|
245 |
180 |
$11K |
| 0002A |
|
239 |
141 |
$10K |
| 90651 |
|
933 |
781 |
$9K |
| 99382 |
|
84 |
78 |
$8K |
| 90474 |
|
396 |
335 |
$8K |
| 85018 |
|
3,161 |
2,552 |
$7K |
| 99408 |
|
255 |
198 |
$6K |
| 0072A |
|
119 |
85 |
$6K |
| 0071A |
|
79 |
57 |
$5K |
| 92552 |
|
8,443 |
6,995 |
$4K |
| D1206 |
Topical application of fluoride varnish |
240 |
211 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
50 |
46 |
$3K |
| 90734 |
|
226 |
220 |
$3K |
| 96161 |
|
781 |
632 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
165 |
142 |
$2K |
| 90619 |
|
820 |
664 |
$2K |
| 90621 |
|
387 |
336 |
$2K |
| 87807 |
|
125 |
97 |
$2K |
| 99173 |
|
8,516 |
7,064 |
$1K |
| 99381 |
|
13 |
12 |
$1K |
| 90686 |
|
995 |
870 |
$742.81 |
| 83718 |
|
60 |
56 |
$499.58 |
| 69210 |
|
15 |
12 |
$432.48 |
| 90633 |
|
599 |
509 |
$289.85 |
| 90677 |
|
247 |
222 |
$289.17 |
| 82465 |
|
60 |
56 |
$265.13 |
| 81003 |
|
161 |
142 |
$264.81 |
| 90715 |
|
258 |
221 |
$243.80 |
| 99406 |
|
12 |
12 |
$156.84 |
| 36416 |
|
980 |
729 |
$34.76 |
| 94760 |
|
66 |
50 |
$10.63 |
| 91300 |
|
588 |
348 |
$0.00 |
| 90710 |
|
106 |
94 |
$0.00 |
| 90670 |
|
924 |
768 |
$0.00 |
| 90707 |
|
30 |
27 |
$0.00 |
| 90648 |
|
47 |
47 |
$0.00 |
| 99000 |
|
116 |
113 |
$0.00 |
| 90744 |
|
209 |
173 |
$0.00 |
| 90698 |
|
1,018 |
829 |
$0.00 |
| 90680 |
|
417 |
354 |
$0.00 |
| 91307 |
|
244 |
171 |
$0.00 |
| 90723 |
|
16 |
16 |
$0.00 |
| 90656 |
|
105 |
96 |
$0.00 |
| 90696 |
|
78 |
63 |
$0.00 |
| 90716 |
|
15 |
15 |
$0.00 |
| 90697 |
|
15 |
15 |
$0.00 |